Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-037986
Filing Date
2024-03-22
Accepted
2024-03-22 18:23:52
Documents
1
Period of Report
2024-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm249605-2_4.html 4  
1 FORM 4 tm249605-2_4.xml 4 3565
  Complete submission text file 0001104659-24-037986.txt   5435
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 24776550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)